Volpara (ASX:VHT) share price rises on pleasing business update

The Volpara Health Technologies Ltd (ASX:VHT) share price has gone up after the ASX healthcare share revealed a solid business update.

You’re reading a free article on Rask. Join 4,000+ Australians who get our expert advice, tools, exclusive research and investment recommendations. Get your 30-day trial for $1! Learn more

The Volpara Health Technologies Ltd (ASX: VHT) share price has gone up after the ASX healthcare share revealed a solid business update.

Volpara’s software is used to “better understand cancer risk, empower patients in personal care decisions, and guide recommendations about additional imaging, genetic testing, and other interventions.”

Cashflow, credit and Microsoft

Volpara told investors a little about its quarterly cashflow.

It said that since its revised strategy that was implemented in July 2022, with staffing changes completed in late August 2022, the business has “operated on an approximately free cash flow break-even basis” with the FY24 first quarter delivering “another strong quarter of cash inflows”.

The company revealed it had over NZ$12 million of cash on hand at the end of the FY24 first quarter and that there is “repeatable operating cash flow positivity in sight.”

Credit facility reduction

Last year the company obtained a NZ$10 million revolving credit facility. But, due to its growing cashflow, it has decided to reduce the facility as it’s no longer considered necessary. The facility will now be NZ$2.5 million.

It was paying a line fee of 1.5% per year for the available facility, so it’s going to save NZ$112,500 per year. It will evaluate the cash position over the next six months, with the possibility of reducing the facility further.

Microsoft

The global tech giant chose Volpara as the winner for the healthcare and life sciences partner of the year award, chosen from over 4,200 submitted nominations from more than 100 countries.

This award “recognises a partner organisation that excels at providing innovative healthcare and life sciences solutions based on Microsoft cloud technologies.”

Last year, Microsoft provided guidance on using Microsoft’s Azure machine learning platform to improve Volpara’s breast arterial calcifications (BAC) model and data progressing. The project marked the beginning of a new application anticipated to enter Volpara into a new area of care.

Management comments

The Volpara CEO and Managing Director Teri Thomas said:

We are double delighted about this announcement. From a financial perspective, Volpara’s strategy continues to play out ahead of guidance, giving us the confidence to reduce reliance on banking facilities while simultaneously reducing costs.

Final thoughts on the Volpara share price

I think Volpara is a great business and that its improving cashflow position shows it can continue to do well if it keeps growing revenue, which it is.

Earnings can significantly improve from here, in my eyes, because of all of the new risk-related services it can encourage its existing client base to use.

It’s one of the most promising businesses around in my opinion.

CSL, Xero, ANZ... the ASX is beaten up

Right now, only brave investors are buying. Is ASX Reporting Season your KEY opportunity to act? Buy, or sell.

This coming Monday night, our two most experienced professional investors, Owen Rask and Leigh Gant, are hosting an exclusive and rare webinar on the what to watch this ASX reporting season. LIVE and free

With over 35 years of combined investing experience, join our Chief Investment Officer and Head of Content for our free Q&A.

We’ll be diving into results from CSL, Pro Medicus (ASX: PME), ANZ Bank and more. It’s absolutely free to join us. Take advantage of this volatility with our free playbook. Simply click here to view the topics.

At the time of publishing, Jaz does not have a financial or commercial interest in any of the companies mentioned.

A $50,000 per year passive income special report

Join more 50,000 Australian investors who read our weekly investing newsletter and we’ll send you our passive income investing report right now.

How can Rask help you?

About Rask

Learn more about us, our your community and our mission.

Rask investing philosophy

Nearly 15 years later.
It's still a work in progress.

Online investment community

You won't find our investment community on Facebook or Reddit because it's secure, free and available now.

Join 250,000+ podcast listeners

250,000 investors tune into the Rask podcasts every month. Find out why.

Find a financial planner

Australia's financial experts. At your doorstep.

Free finance courses

35,000 students have enrolled in free Rask courses. We're on a mission to 100,000.

Subscribe to Rask's free investor newsletter

53,000 Australian investors subscribe to our Sunday newsletter... and love it! It's free.

$50 million invested

We manage almost $50 million on behalf of Aussies. Discover how you can invest with us.

Better investing starts here.

Want to level-up your analytical skills and investing insights but don’t know where to start? Join 50,000 Australian investors on our mailing list and we’ll send you our favourite podcasts, courses, resources and investment articles every Sunday morning. Grab a coffee and let Owen and the team bring you the best  insights.

Subscribe to Rask's free investor newsletter

Kick off your week with our pick of podcasts, courses and investing resources to keep your finger on the Rask pulse!

Here you go: A $50,000 per year passive income special report

Join more 50,000 Australian investors who read our weekly investing newsletter and we’ll send you our passive income investing report right now.

Simply enter your email address and we’ll send it to you. No tricks. Unsubscribe anytime.

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.